El-Guindy et al. 2023, reported that high expression of BECN1 and not lower expression is associated with poorer prognosis using cox regression model as well as its association with higher tumor grade, stage, and nodal metastasis in TNBC patients (El-Guindy et al. 2023). This evidence concerns the gene BECN1 and neoplasm.